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Abstract
We report the case of a patient who noticed muscle weakness in his left arm 5 years earlier. On examination, a
biloculate mass was observed in the left supraclavicular area, and Tinel’s sign caused paresthesia in his left arm.
Magnetic resonance imaging showed a continuous, multinodular, plexiform tumor from the left C5 to C7 nerve
root along the course of the brachial plexus to the left brachia. Tumor excision was attempted. The median and
musculocutaneous nerves were extremely enlarged by the tumor, which was approximately 40 cm in length, and
showed no response to electric stimulation. We resected a part of the musculocutaneous nerve for biopsy and
performed latissimus dorsi muscle transposition in order to repair elbow flexion. Morphologically, the tumor
consisted of typical Antoni A areas, and immunohistochemistry revealed a Schwann cell origin of the tumor cells
moreover, there was no sign of axon differentiation in the tumor. Therefore, the final diagnosis of plexiform
Schwannoma was confirmed.
Keywords: brachial plexus, giant, plexiform schwannoma
Background
Plexiform Schwannoma is a rare variant of Schwannoma
that accounts for only 5% of all Schwannomas, which
typically shows a plexiform or multinodular growth pat-
tern mimics plexiform neurofibroma. It was first
described by Harkin and Reed in 1978 [1]. Plexiform
Schwannoma usually develops in the dermis or subcuta-
neous tissue, and it is uncommon for the Schwannoma
to develop in deep-seated nerves. Its histological features
include Antoni A and B areas, diffuse and strong posi-
tivity with immunohistochemical markers like S-100,
laminin and collagen type IV.
On the other hand, plexiform neurofibroma lacks
Antoni A and B areas of schwannoma and shows weak
S-100 positivity. Plexiform schwannoma shows up to 5%
association with neurofibromatosis-2 and schwannoma-
tosis, but has no association with neurofibromatosis-1
like plexiform neurofibroma [2,3]. This report describes
the rare case of a giant plexiform Schwannoma in the
brachial plexus.
Case presentation
The patient was a 64-year-old male. More than 30 years
earlier, he had experienced numbness in his left upper
extremity. By his own account, he had undergone sur-
gery and was diagnosed with a brachial plexus tumor.
He stopped visiting the hospital after the surgery, no
records of the surgery remain and the details thereof are
unknown. The patient was diagnosed with diabetes mel-
litus 2 years earlier. He had no family history of a simi-
lar tumor. The patient noticed muscle weakness in his
left arm 5 years earlier, but never visited a medical facil-
ity. Thereafter, the muscle weakness worsened, and he
finally visited a local doctor 2 years earlier. His upper
extremity was far from functional, and so he was
referred to our hospital for further examination and
treatment.
On examination a biloculate mass was observed in the
left supraclavicular area, and Tinel’s sign caused para-
esthesia in his left arm. There was no evidence of the
other tumor anywhere on his body. We found no café-
au-lait spots or other signs of Recklinghausen disease
neither.
Manual muscle testing of his left upper extremity
revealed the following results: deltoid [1], biceps [1],
brachioradialis [0], triceps [4], extensor digitorum [2],
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extensor pollicis longus [2], extensor indicis [2], exten-
sor carpi radialis [4], extensor carpi ulnaris [4], flexor
carpi radialis [0], flexor carpi ulnaris [5], pronator teres
[0], pronator quadratus [0], flexor digitorum superficiali
[I-IV][0], flexor digitorum profindus (index finger) [0]
and II-IV [5], flexor pollicis longus [0], flexor pollicis
brevis [0], and flexor digiti minimi [0]. There was sen-
sory loss in his axillary nerve, lateral brachial cutaneous
nerve, and median nerve. The ulnar nerve was intact.
Therefore, impairment of the lateral, posterior, and part
of the median cord of the brachial plexus was suspected.
There were no abnormal findings in his cervical radio-
graphy. Magnetic resonance imaging showed a continu-
ous, multinodular, plexiform tumor from the left C5 to
C7 nerve root along the course of the brachial plexus to
the left brachia. The tumor showed the same intensity
as the muscle on T1-weighted images and slightly
higher intensity on T2-weighted images. Gadolinium-
enhanced images showed no enhancement of the tumor.
There was no sign of the tumor inside the vertebral
canal (Figure 1).
Tumor excision was attempted via exploration from
the axilla to the cubital fossa. There was no abnormality
in the ulnar nerve, but the median and musculocuta-
neous nerves were extremely enlarged by the tumor.
Judging from the MRI and operative findings, the length
of the tumor was approximately 40 cm in length(Figure
2). We haven’t done electrophysiological examinations
prior to the operation, so we performed electric stimula-
tion during the operation. The tumor showed no
response to it. Therefore, we terminated tumor enuclea-
tion, excised part of the musculocutaneous nerve (about
5 cm) for pathological examination, and performed
latissimus dorsi muscle transposition in order to repair
elbow flexion function. The latissimus dorsi muscle is
innervated by C6-C8 nerve roots, mainly C7 nerve root.
According to the patient’s physical findings, C7 nerve
root was possibly involved by the tumor. We have con-
sidered the transposition of the sternum part of the pec-
toralis major muscle which is innervated by C8-Th1
nerve roots, but since latissimus dorsi muscle main-
tained as strong muscle contraction as the pectoralis
m a j o r ,a n dw ew e r ec o n f i d e n to ft h el a t i s s i m u sd o r s i
muscle transposition from the past experiences, we have
decided to perform the latissimus dorsi muscle
transposition.
The excised specimen was formalin-fixed, paraffin-
embedded, and sectioned for pathological evaluation.
We performed hematoxylin and eosin staining, Masson
trichrome staining, and immunohistochemistry for S-
100 protein and neurofilamment.
Histologically, the tumor consisted of varying hyper-
trophic peripheral nerve fascicules showing a plexiform
pattern, along with fibrous connective tissues (Figure
3-A). The tumor was mainly composed of Antoni A
areas that showed dense fascicular and interlacing pro-
liferation of spindle-shaped tumor cells without nota-
ble nuclear atypia. A nuclear palisading pattern was
focally observed in the tumor (Figure 3-B). Typical
Antoni B areas were not observed in the tumor. The
fibrous connective tissues around the tumor were
roughly stained with Masson trichrome (Figure 3-C).
Immunohistochemistry results showed that the tumor
cells were strongly positive for S-100 protein (Figure
3-D). There were no neurofilamment-positive areas
indicative of axons located inside or outside the tumor
(Figure 4).
 
Figure 1 MRI images. Magnetic resonance imaging images. Magnetic resonance imaging showed a continuous, multinodular, plexiform tumor
from the left C5 to C7 nerve root along the course of the brachial plexus to the left brachia. The tumor showed the same intensity as the
muscle on T1-weighted images (T1WI), and slightly higher intensity on T2-weighted images (T2WI). Gadolinium-enhanced images (T1WI+C)
showed no enhancement of the tumor. There was no sign of the tumor inside the vertebral canal.
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A areas, which are generally found in Schwannomas but
not in neurofibromas, and immunohistochemistry results
revealed a Schwann cell origin of the tumor cells. These
features made us suspect that the tumor was a Schwan-
noma. However, it is well known that Schwannoma-like
lesions can be seen in some neurofibromas [4,5]. How-
ever in our case, there was absolutely no sign of axon dif-
ferentiation in the tumor, and we observed no
neurofilament-positive areas. Therefore, the final diagno-
sis of plexiform Schwannoma was confirmed.
Sixteen months after the operation, no progression in
paralysis was observed. By latissimus dorsi transposi-
tion, the patient acquired elbow flexion up to 100
degrees (Figure 5). Collateral suture of the left flexor
digitorum profundus I to flexor digitorum profundus
II-IV, metacarpophalangeal joint arthrodesis of the left
thumb, and reconstruction of the pollicis opponens
   
Figure 2 operative findings. Operative findings. The median and
musculocutaneous nerves were extremely enlarged by the tumor
and showed no response to electric stimulation. There was no
abnormality in the ulnar nerve. Triangle; ulnar nerve Wide arrow;
enlarged median nerve Narrow arrow; musculocutaneous nerve.
 
Figure 3 Histological findings of the excised specimen. A. Hematoxylin and eosin staining (×40). Hematoxylin and eosin staining (×40).
The tumor consisted of varying hypertrophic peripheral nerve fascicules showing a plexiform pattern, along with fibrous connective tissues.B.
Hematoxylin and eosin staining (×100). Hematoxylin and eosin staining (×100). Antoni A areas, which composed main part of the tumor. A
nuclear palisading pattern was focally observed. C. Masson trichrome staining (×100). Masson trichrome staining (×100). The fibrous
connective tissues around the tumor were roughly stained. Immunohistochemistry for S-100 protein (×100). Immunohistochemistry for S-100
protein (×100). The tumor cells were strongly positive for S-100 protein.
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living.
Discussion
There have been few case report of plexiform Schwan-
nomas in deep-seated nerves, as observed in our patient
[6]. However, none of these reported Schwannomas was
as large as that in our patient.
The differential diagnosis of plexiform Schwannoma
with plexiform neurofibroma is very important.
Schwannomas are benign encapsulated tumors origi-
nating from Schwann cells in the peripheral nervous
system. Neurofibromas are benign, heterogeneous per-
ipheral nerve sheath tumors arising from the
connective tissue of peripheral nerve sheaths, especially
the endoneurium. Neurofibromas are mostly solitary:
however, when associated with neurofibromatosis type
I, they can occur as multiple tumors. Optic glioma,
Lisch nodules, and sphenoid dysplasia can also be
found in neurofibromatosis type I, but non of them
was found in our case. We must consider the possibi-
lity of neurofibromatosis type II. Definite criteria for
neurofibromatosis type II include bilateral vestibular
Schwannoma or first-degree family members of neuro-
fibromatosis type II, and unilateral vestibular schwan-
noma diagnosed younger than 30 years or any two of
meningioma, glioma, or schwannoma [7,8]. Another
differential diagnosis is schwannomatosis. Schwanno-
matosis is generally a sporadic, nonfamilial condition
that presents in older age groups with longer life
expectancy, with two or more pathologically proven
schwannomas. Definite criteria for schwannomatosis
include the lack of neurofibromatosis type II mutations
[5]. It is recently reported that trisomy of chromo-
somes 17 and 18 are present in a plexiform schwan-
noma [6]. We could not obtain approval of DNA
analysis from the patient, but since his schwannoma
was solitary, and there were no signs of vestibular
schwannoma, glioma or meningioma, the possibility of
neurofibromatosis type II and schwannomatosis were
denied.
In our case, the clinical features and the appearance of
the tumor was rather like that of plexiform neurofi-
broma. The patient did not show any café-au-lait spots,
which precluded the presence of neurofibromatosis type
I. The final diagnosis was thus based on microscopic
tumor findings. In our case, the findings were specific to
Schwannoma, namely, Antoni type A areas, anti-S-100
protein staining, minimal fibrous tissues, and no evi-
dence of axon growth inside the tumor, which is most
important. We excised only a part of the huge tumor;
therefore, we cannot completely deny the possibility of
Schwannoma-like lesions in a plexiform neurofibroma.
However, since there were no neurofilament-positive
areas inside or outside the tumor, we are confident in
our diagnosis of Schwannoma.
In our case, the patient experienced paralysis for
q u i t eal o n gt i m e ,a n dw ec o u l dt h u sn o te x p e c t
improvements in nerve function. In addition, because
t h et u m o rw a st o ol a r g et oe x c i s e ,w ep e r f o r m e do n l y
a biopsy. Whether or not we should have instead
resected the whole tumor is controversial. In past case
reports of plexiform Schwannomas occurred in deep-
seated peripheral nerves, paralysis was not present or
very mild (Table 1). Furthermore, in all cases, the size
of the tumor was much smaller than that observed in
our case. Deep seated plexiform schwannoma can
show necrosis and myxoid change in 12% of the
   
Figure 4 Immunohistochemistry for neurofilament (×100).
Immunohistochemistry for neurofilament (×100). There were no
neurofilamment positive areas indicative of axons inside or outside
the tumor.
   
Figure 5 Sixteen months after the operation. Sixteen months
after the operation. By latissimus dorsi transportation, the patient
acquired elbow flexion up to 100 degrees.
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ity was seen in the excised specimen. However, consid-
ering the severe neurological deficit, necrotic change
might have occurred somewhere in the tumor.
We must consider the possibility of worsening paraly-
sis and malignancy when contemplating tumor resec-
tion. If the tumor develops another fascicle, the
paralysis may become worse. However, in our patient,
considering his history the development of the tumor
must have been very slow. Furthermore, according to
the pathological diagnosis, the tumor was a plexiform
Schwannoma, which is associated with a very low possi-
bility of malignancy. Instead, we have found only one
case report describing malignization of a plexiform
Schwannoma [9].
Conclusions
We have experienced the rare case of a giant plexiform
Schwannoma in the brachialp l e x u s .T h ea f f e c t e d
nerves did not react to electric stimulation during the
operation, and tumor invasion was extremely extensive,
we therefore decided only to remove part of the tumor
as biopsy, and changed the purpose of the operation
from tumor removal the to reconstruction of elbow
function. The diagnosis of plexiform Schwannoma had
been made based on the pathological study. The condi-
tion of the patient remains satisfactory thus far, but
careful observation of the progression of paralysis is
necessary.
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